World's Best Scientists 2026 revealed!
Alan Kenneth Burnett

Alan Kenneth Burnett

D-Index & Metrics

Medicine

D-Index
104
Citations
53415
World Ranking
6933
National Ranking
672

Overview

Alan Kenneth Burnett is affiliated with the University of Glasgow in the United Kingdom. Their research focuses primarily on Medicine, with significant contributions to Biochemistry, Genetics, and Molecular Biology. Within these fields, their work centers on subfields such as Hematology, Molecular Biology, Genetics, Oncology, and Public Health, Environmental and Occupational Health.

The scientist's research topics include Acute Myeloid Leukemia (AML), Hematopoietic Stem Cell Transplantation, Myeloproliferative Neoplasms, Histone Deacetylase Inhibitors, Acute Lymphoblastic Leukemia, Multiple Myeloma, and Cancer Genomics and Diagnostics.

Frequent co-authors collaborating with Burnett include:

  • Nigel H. Russell
  • Robert K. Hills
  • Mike Dennis
  • Amanda Gilkes
  • Ian Thomas

Burnett's scholarly output is often published in notable venues such as:

  • British Journal of Haematology
  • Blood
  • Nature Communications
  • Leukemia
  • Clinical Lymphoma Myeloma & Leukemia

Among recent papers, Burnett is author or co-author of:

  • "Molecular MRD status and outcome after transplantation in NPM1-mutated AML," 2020, Blood
  • "Unified classification and risk-stratification in Acute Myeloid Leukemia," 2022, Nature Communications
  • "Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission," 2024, Blood
  • "Genome-wide association study identifies susceptibility loci for acute myeloid leukemia," 2021, Nature Communications
  • "AML: New Drugs but New Challenges," 2020, Clinical Lymphoma Myeloma & Leukemia

Best Publications

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

    David Grimwade;Helen Walker;Fiona Oliver;Keith Wheatley

  • Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

    David Grimwade;Robert K. Hills;Anthony V. Moorman;Helen Walker

  • Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

    Mark A. Dawson;Rab K. Prinjha;Antje Dittmann;George Giotopoulos

  • Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Miguel A. Sanz;David Grimwade;Martin S. Tallman;Bob Lowenberg

  • In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

    Anthony H. Goldstone;Susan M. Richards;Hilliard M. Lazarus;Martin S. Tallman

  • Therapeutic Advances in Acute Myeloid Leukemia

    Alan Kenneth Burnett;M. Wetzler;B. Lowenberg

  • The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

    David Grimwade;Helen Walker;Georgina Harrison;Fiona Oliver

  • The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

    Rosemary E. Gale;Claire Green;Christopher Allen;Adam J. Mead

  • Assessment of Minimal Residual Disease in Standard-Risk AML.

    Adam Ivey;Robert Kerrin Hills;Michael A. Simpson;Jelena V. Jovanovic

  • Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial

    Alan Kenneth Burnett;Anthony H. Goldstone;Richard M. F. Stevens;Ian M. Hann

  • A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment†‡

    Alan Kenneth Burnett;Donald Milligan;Archie G. Prentice;Anthony H. Goldstone

  • Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

    Nicolas Goardon;Emanuele Marchi;Ann Atzberger;Lynn Quek

  • Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

    Jacob M. Rowe;Georgina Buck;Alan Kenneth Burnett;Raj Chopra

  • Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: A meta-analysis of individual patient data from randomised controlled trials

    Robert Kerrin Hills;Sylvie Castaigne;Frederick R. Appelbaum;Jacques Delaunay

  • Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    Alan Kenneth Burnett;Robert Kerrin Hills;Donald Milligan;Lars Kjeldsen

  • Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia

    Tino Schenk;Weihsu Claire Chen;Stefanie Göllner;Louise Howell

  • A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties.

    Keith Wheatley;Alan Kenneth Burnett;Anthony H. Goldstone;Richard G. Gray

  • Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial.

    Anthony H. Goldstone;Alan Kenneth Burnett;Keith Wheatley;Alastair G. Smith

  • Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC Trial

    Alan K. Burnett;David Grimwade;Ellen Solomon;Keith Wheatley

Frequent Co-Authors

Robert Kerrin Hills
Robert Kerrin Hills University of Oxford
Nigel H. Russell
Nigel H. Russell University of Nottingham
Keith Wheatley
Keith Wheatley University of Birmingham
David C. Linch
David C. Linch University College London
David Grimwade
David Grimwade King's College London
Donald Milligan
Donald Milligan University of Birmingham
Anthony H. Goldstone
Anthony H. Goldstone University College Hospital
Mary Frances McMullin
Mary Frances McMullin Queen's University Belfast
Elihu H. Estey
Elihu H. Estey University of Washington
Bob Löwenberg
Bob Löwenberg Erasmus MC

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine opens doors to a wide range of pathways beyond becoming a physician. For those interested in leadership roles within healthcare, pursuing an accelerated healthcare administration degree can be a great fit. These programs are ideal for students aiming to quickly gain the expertise needed to manage hospitals, clinics, or healthcare organizations.

Registered nurses looking to advance their qualifications should consider comprehensive adn to msn bridge programs. These transitions allow nurses with an associate degree to efficiently earn a master’s degree, opening doors to advanced practice roles and leadership opportunities in nursing.

Health and wellness enthusiasts might find rewarding work by obtaining online degrees in nutrition. These programs equip graduates to educate patients, plan dietary programs, or work in public health settings.

Working professionals in healthcare administration often benefit from flexible education. If you’re considering leadership advancement while juggling a career, it’s important to ask whats the best online mha program for working adults. Top online MHA programs offer convenience and accreditation, ensuring you stay competitive and prepared for senior roles in the healthcare industry.

Best Scientists Citing Alan Kenneth Burnett

Trending Scientists

Recently Published Articles